FDA advisers vote against sleep peptide as they debate safety and health claims
An FDA advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.